The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea.
Badran Mohammad, Mashaqi Saif, Gozal David·Expert opinion on therapeutic targets
: Gut dysbiosis is assumed to play a role in obstructive sleep apnea (OSA)-associated morbidities. Pre- and probiotics, short chain fatty acids (SCFA) and fecal matter transplantation (FMT) may offer potential as novel therapeutic strategies that target this gut dysbiosis. As more mechanisms of OSA-induced dysbiosis ar…